If you have money to sink into the share market, then the ASX growth shares in this article could be worth considering.
That's because they have been named as shares to buy by analysts at Macquarie Group Ltd (ASX: MQG) following the market selloff.
Here's what the broker is saying about them:
Image source: Getty Images
Breville Group Ltd (ASX: BRG)
The first ASX growth share that could be a buy according to Macquarie is appliance manufacturer Breville.
The broker believes that the company's outlook is positive due to new product developments and its ongoing global expansion. It said:
Earnings outlook continues to be supported by new product development and new market entry. Coffee is the key product, and was the key driver to +13.0% Global Product rev growth (constant currency) in 1H25, with North America +10.9%, EMEA +15.4% and Asia +16.3%.
Macquarie has an outperform rating and $41.10 price target on its shares. This implies potential upside of 29% for investors over the next 12 months.
Lovisa Holdings Ltd (ASX: LOV)
Another ASX growth share that gets the thumbs up is fashion jewellery retailer Lovisa.
As with Breville, the company's global expansion is a reason to be positive. Macquarie expects the company to grow significantly as it rolls out new stores across the world.
The broker also sees positives from its leadership change. It explains:
We expect significant growth over coming years supported by store roll-out and EBIT margin expansion. […] We continue to expect strong store roll-outs across several markets, with the ability to grow revenue per store. The succession of the current CEO should lead to significant cost savings, and we expect EBIT margin expansion as a result.
Macquarie has an outperform rating and $33.40 price target on Lovisa's shares. This suggests that upside of 34% is possible for investors from current levels.
Temple & Webster Group Ltd (ASX: TPW)
Finally, online furniture retailer Temple & Webster could be an ASX growth share to buy according to Macquarie.
After delivering a very strong result during the first half, the broker expects more of the same in the second. It said:
Sales +24% in 1H25 vs pcp, accelerating into the end of CY24. We expect top-line growth to continue to be supported by active customer growth (+22% in 1H25), and ongoing conversion improvement (+7% in 1H25). […] Sales growth supported by active customers, improved conversion and increased revenue per customer, with AI to drive margin expansion.
The broker has an outperform rating and $17.60 price target on its shares. Based on its current share price of $16.73, this implies modest upside of 5.2% for investors between now and this time next year.
